H.R. 3302 would reauthorize the appropriation of $145 million annually from 2026 through 2030 for the Healthy Start program, which provides grants to areas with high rates of infant mortality and other adverse perinatal outcomes. In 2025, $145 million was provided for those purposes.
Based on historical spending patterns for those activities and assuming appropriation of authorized amounts, CBO estimates that implementing H.R. 3302 would cost $557 million over the 2026-2030 period and $153 million after 2030.
The costs of the legislation, detailed in Table 1, fall within budget function 550 (health).
Table 1.
Estimated Increases in Spending Subject to Appropriation Under H.R. 3302
By Fiscal Year, Millions of Dollars
2026
2027
2028
2029
2030
2026-2030
Authorization
145
145
145
145
145
725
Estimated Outlays
29
109
135
142
142
557
The CBO staff contact for this estimate is Ian Shayne. The estimate was reviewed by Chad Chirico, Director of Budget Analysis.
